XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.3

REVENUE (Tables)

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

Schedule of disaggregation of revenue

The following table presents the Company’s revenues disaggregated by revenue source:

						Three Months Ended September 30,												Nine Months Ended September 30,
(In thousands)						2024						2023						2024						2023
Screening
Medicare Parts B & C						$	201,423					$	173,624					$	570,550					$	521,370
Commercial						289,637						253,401						827,509						732,182
Other						53,841						44,988						153,246						124,443
Total Screening						544,901						472,013						1,551,305						1,377,995
Precision Oncology
Medicare Parts B & C						$	47,080					$	46,383					$	142,597					$	141,352
Commercial						47,685						44,430						143,572						135,574
International						49,433						38,599						140,688						111,453
Other						19,556						26,913						67,281						80,552
Total Precision Oncology						163,754						156,325						494,138						468,931
COVID-19 Testing						$	—					$	—					$	—					$	5,955
Total						$	708,655					$	628,338					$	2,045,443					$	1,852,881

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration